Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. - Wikidata - awgldk - TriplyDB

Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.

Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.

http://www.wikidata.org/entity/Q35556455

about

Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells.Engraftment of Human Primary Acute Myeloid Leukemia Defined by Integrated Genetic Profiling in NOD/SCID/IL2rγnull Mice for Preclinical Ceramide-Based Therapeutic Evaluation.Gaucher's disease and cancer: a sphingolipid perspective Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia.C6-ceramide nanoliposome suppresses tumor metastasis by eliciting PI3K and PKCζ tumor-suppressive activities and regulating integrin affinity modulation.Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway.Novel chemotherapeutic drugs in sphingolipid cancer research.Nanodrug delivery in reversing multidrug resistance in cancer cells.Nanoformulations for therapy of pancreatic and liver cancers.Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury.Major apoptotic mechanisms and genes involved in apoptosis.Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.Glucosylceramide synthase promotes Bcl-2 expression via the ERK signaling pathway in the K562/A02 leukemia drug-resistant cell line.Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.Ceramide nanoliposomes as a MLKL-dependent, necroptosis-inducing, chemotherapeutic reagent in ovarian cancer.Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.Role of sphingolipids in senescence: implication in aging and age-related diseases

P2860

Q28084270-996D6862-A02D-4C7A-AC96-FEE05AA2F721 Q30276873-0B9831F6-7B18-4430-8E23-F8B23AA57300 Q30279055-B70B2EE6-6F5E-4B54-BC80-179F88C7F508 Q30300370-E2D6FE81-B695-4704-B427-C21CE562AAAB Q30300775-2D2A8EBB-4FD7-43E3-90D8-B8F2CD10E833 Q30353992-581B38B1-62CC-42B8-A1D7-8643285226F6 Q34333982-0E936FF4-17C5-4A1B-B4DB-2037577E6AC4 Q34975327-9AEE46B5-B7C9-4F60-B953-97EB45806D5F Q35075838-A5957133-19CC-40BE-B56D-8402B9310A6C Q35198193-73BF5E1F-B680-41EF-96BC-8324D2BFBE18 Q36392653-A889BFB8-B917-4663-86A4-9EB1A430F625 Q37631156-51B575C0-F99E-4C8F-B54D-3FD11674AFD8 Q37721276-CF0A6560-48EF-4855-8857-624A9350E803 Q38234908-743EA0F3-9510-4F5F-B705-6AD3CD657B9E Q38495105-304C29ED-FB8E-48EB-A5D3-B029AB46185C Q38793821-9DFE7B2C-EB98-40DC-9F2B-973E886E628E Q38802454-B18A9967-98F1-42C8-A5D1-118FF7DBD2D4 Q38831997-40C19D5A-51F4-40EB-B98D-D47195EF8636 Q38950710-BB39DFE5-0746-4312-A7F6-8B553F89F6F6 Q41135883-EA1B651D-A4C3-4E66-8054-25F4B61E82B7 Q45071225-E802B905-CC80-4596-8361-A45E2AB9BEBB Q50058499-63CA0B19-F0CF-4E2F-A208-1C92EE9F299F Q57177438-CA9D3489-203F-4679-A2A1-A27CC1036534

P2860

Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.

http://www.wikidata.org/entity/Q35556455

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Combinatorial therapies improv ...... eramide for pancreatic cancer.

@ast

Combinatorial therapies improv ...... eramide for pancreatic cancer.

@en

type

label

Combinatorial therapies improv ...... eramide for pancreatic cancer.

@ast

Combinatorial therapies improv ...... eramide for pancreatic cancer.

@en

prefLabel

Combinatorial therapies improv ...... eramide for pancreatic cancer.

@ast

Combinatorial therapies improv ...... eramide for pancreatic cancer.

@en

P1433

Q35556455-0F96DB0B-B052-4391-9E57-3EA9C9D3004E

P1476

Q35556455-E0E1F765-4006-4CDC-B4A8-C68ED5F8BE1A

P2093

Q35556455-22E3B566-E5D1-4597-B11F-F86EA3FD68C3

Q35556455-24CA6C27-D71A-4AB4-B28D-7839D445D705

Q35556455-2BCE6D1D-E481-4029-82F6-C007B2905875

Q35556455-38BA42D0-D6FB-466C-8CB7-7CB233F9B9DD

Q35556455-3E444951-4AD0-4422-AB0B-48A361D715E4

Q35556455-6C1227A4-6F37-42A6-8F56-69C556BF6EB9

Q35556455-8E330AB9-E986-4807-8AC3-2C3C371FA040

Q35556455-99801D71-F758-41C7-9D89-62C959436411

Q35556455-A0F8C36D-8F0D-46CD-A959-2BE8D910A826

Q35556455-A4572985-DB2B-4778-A921-F806400A0EE7

P2860

Q35556455-05CB4B0B-352C-4A9D-9E3B-9F3D88FD84EE

Q35556455-1280831F-CF26-4842-82F2-B1D653F5610A

Q35556455-1C3AC0F2-96DD-4426-9911-EA83D266E5F8

Q35556455-2749EABA-61C4-45D8-8036-502EDF6D31E4

Q35556455-2C54BEAB-65E6-4BC7-BB59-3A30F5D6FEF6

Q35556455-3447BAF4-AE6E-42F3-9EFA-C607FD1F56FB

Q35556455-3E685E4B-F2AF-471D-93D3-20B8D2ECA26B

Q35556455-44BF9E59-E333-4564-87F4-F35B0A9721BE

Q35556455-45A6A25B-1AAD-4482-B510-E38ABAA33AFF

Q35556455-479B2F4B-5E01-466E-9953-96558E1515D8

P304

Q35556455-94E42876-F713-4A40-8FFD-4002A99A2977

P31

Q35556455-CBAEF17F-220A-4179-BBBB-C00464E7F502

P356

Q35556455-B435BFEA-F5B7-47F5-91E5-4125276F7BE7

P433

Q35556455-745DDA19-CEFD-437B-8C73-66B677EA9189

P478

Q35556455-4B15D3AE-E5CE-40AE-8F59-77D35C3A3EB6

P50

Q35556455-0434E322-C690-4017-AF78-9F4CFCD33109

P577

Q35556455-BEFF473A-828A-4893-9A68-4E97A216A652

P5875

Q35556455-9C2F21E4-883A-4BBA-B083-0FA46FF10606

P698

Q35556455-56238687-8B08-43EB-9405-B4C748FF873F

P932

Q35556455-B9CAC0A8-C748-4EAE-B725-558A434BD95D

P356

P1433

Cancer Biology and Therapy

P1476

Combinatorial therapies improv ...... eramide for pancreatic cancer.

@en

P2093

Brian M Barth

http://www.w3.org/2001/XMLSchema#string

Hephzibah Rani S Tagaram

http://www.w3.org/2001/XMLSchema#string

Hua Cheng

http://www.w3.org/2001/XMLSchema#string

James M Kaiser

http://www.w3.org/2001/XMLSchema#string

Jennifer L Fritz

http://www.w3.org/2001/XMLSchema#string

Kevin F Staveley-O'Carroll

http://www.w3.org/2001/XMLSchema#string

Melissa A Tran

http://www.w3.org/2001/XMLSchema#string

Myles C Cabot

http://www.w3.org/2001/XMLSchema#string

Nicole A DiVittore

http://www.w3.org/2001/XMLSchema#string

Sriram S Shanmugavelandy

http://www.w3.org/2001/XMLSchema#string

P2860

Roles of bioactive sphingolipids in cancer biology and therapeutics

Therapeutic nanoparticles for drug delivery in cancer

Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains

Cancer statistics, 2007

Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.

Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.

Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo

Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia

Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance.

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

P304

574-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.12.7.15971

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51527405

http://www.w3.org/2001/XMLSchema#string

P698

21795855

http://www.w3.org/2001/XMLSchema#string

P932

3218384

http://www.w3.org/2001/XMLSchema#string